Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 150 of 1705 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/07/22
End: 10/01/22
Due: 10/01/23
Phase: N/A
Priority: Normal
Start: 01/15/20
End: 09/01/20
Due: 09/01/21
Phase: N/A
Priority: Normal
Start: 05/18/22
End: 11/15/22
Due: 11/15/23
Phase: N/A
Priority: Normal
Start: 06/15/22
End: 02/28/23
Due: 02/28/24
Phase: N/A
Priority: Normal
Start: 02/01/22
End: 07/30/22
Due: 07/30/23
Phase: N/A
Priority: Normal
Start: 10/30/21
End: 12/31/21
Due: 12/31/22
Phase: N/A
Priority: Normal
Start: 05/15/24
End: 07/30/24
Due: 07/30/25
Phase: N/A
Priority: Normal
Start: 05/08/23
End: 01/31/24
Due: 01/31/25
Phase: N/A
Priority: Normal
Start: 10/13/20
End: 07/15/21
Due: 07/15/22
Phase: N/A
Priority: Normal
Start: 03/01/21
End: 08/31/22
Due: 08/31/23
Phase: N/A
Priority: Normal
Start: 08/10/22
End: 09/30/22
Due: 09/30/23
Phase: N/A
Priority: Normal
Start: 08/13/20
End: 03/20/21
Due: 03/20/22
Phase: N/A
Priority: Normal
Start: 03/15/19
End: 11/30/20
Due: 11/30/21
Phase: N/A
Priority: Normal
Start: 05/15/24
End: 07/31/24
Due: 07/31/25
Phase: N/A
Priority: Normal
Start: 03/01/23
End: 06/01/23
Due: 06/01/24
Phase: N/A
Priority: Normal
Start: 05/30/21
End: 02/28/22
Due: 02/28/23
Phase: N/A
Priority: Normal
Start: 12/01/23
End: 02/15/24
Due: 02/15/25
Urdu Version Of Nottingham Extended Activities Of Daily Living Scale: Reliability And Validity Study
Phase: N/A
Priority: Normal
Start: 05/30/21
End: 07/12/23
Due: 07/12/24
Phase: N/A
Priority: Normal
Start: 07/01/20
End: 12/08/20
Due: 12/08/21
Phase: N/A
Priority: Normal
Start: 06/14/24
End: 09/14/24
Due: 09/14/25
Phase: N/A
Priority: Normal
Start: 09/30/21
End: 07/15/22
Due: 07/15/23
Phase: N/A
Priority: Normal
Start: 01/01/24
End: 08/30/24
Due: 08/30/25
Phase: N/A
Priority: Normal
Start: 04/25/22
End: 01/10/23
Due: 01/10/24
Phase: N/A
Priority: Normal
Start: 11/30/21
End: 07/31/22
Due: 07/31/23
Phase: N/A
Priority: Normal
Start: 10/01/23
End: 02/01/24
Due: 02/01/25